Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Philip W. Pemberton"'
Autor:
Emma J. Crosbie, Henry C. Kitchener, Richard J. Edmondson, Michelle L. MacKintosh, Michelle Needham, Philip W. Pemberton, Joseph Shaw, James Bolton, Bhavna Lakhiani, Matthew Gittins, Jennifer L. Allen, Abigail E. Derbyshire
Immunohistochemical antibodies and protocols
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8426ac5cf0e9a11b4870c9a5b050199a
https://doi.org/10.1158/1940-6207.22533206
https://doi.org/10.1158/1940-6207.22533206
Autor:
Emma J. Crosbie, Henry C. Kitchener, Richard J. Edmondson, Michelle L. MacKintosh, Michelle Needham, Philip W. Pemberton, Joseph Shaw, James Bolton, Bhavna Lakhiani, Matthew Gittins, Jennifer L. Allen, Abigail E. Derbyshire
Obesity is the major etiologic driver for endometrial cancer. The levonorgestrel intrauterine system (LNG-IUS) reduces the risk of endometrial cancer and its precursor, atypical hyperplasia. We assessed feasibility and uptake of the LNG-IUS for prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2513ab71dfeb49247210a1551292efd
https://doi.org/10.1158/1940-6207.c.6546986.v1
https://doi.org/10.1158/1940-6207.c.6546986.v1
Autor:
Emma J. Crosbie, Henry C. Kitchener, W. David Ryder, Joseph Shaw, Philip W. Pemberton, Richard J. Slade, Rahamatulla Latheef, Kyle Gilmour, Sean Burns, Saad Ali, Jennifer L. Allen, Vanitha N. Sivalingam, Zoe Maskell, Sarah J. Kitson
Immunohistochemistry staining protocols
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ab8694cf7bee89d7f1ca48ac3f3d42
https://doi.org/10.1158/1078-0432.22471361.v1
https://doi.org/10.1158/1078-0432.22471361.v1
Autor:
Emma J. Crosbie, Henry C. Kitchener, W. David Ryder, Joseph Shaw, Philip W. Pemberton, Richard J. Slade, Rahamatulla Latheef, Kyle Gilmour, Sean Burns, Saad Ali, Jennifer L. Allen, Vanitha N. Sivalingam, Zoe Maskell, Sarah J. Kitson
Supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aedb79883eeb151c50db31289da530e
https://doi.org/10.1158/1078-0432.22471364
https://doi.org/10.1158/1078-0432.22471364
Autor:
Emma J. Crosbie, Henry C. Kitchener, W. David Ryder, Joseph Shaw, Philip W. Pemberton, Richard J. Slade, Rahamatulla Latheef, Kyle Gilmour, Sean Burns, Saad Ali, Jennifer L. Allen, Vanitha N. Sivalingam, Zoe Maskell, Sarah J. Kitson
Purpose:Endometrioid endometrial cancer is strongly associated with obesity and insulin resistance. Metformin, an insulin sensitizer, reduces endometrial tumor growth in vitro. Presurgical window studies allow rapid in vivo assessment of antitumor ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d0a0625798f85b0fada3a1fc80da235
https://doi.org/10.1158/1078-0432.c.6527864.v1
https://doi.org/10.1158/1078-0432.c.6527864.v1
Autor:
Anie, Naqvi, Michelle L, MacKintosh, Abigail E, Derbyshire, Anna-Maria, Tsakiroglou, Thomas D J, Walker, Rhona J, McVey, James, Bolton, Martin, Fergie, Steven, Bagley, Garry, Ashton, Philip W, Pemberton, Akheel A, Syed, Basil J, Ammori, Richard, Byers, Emma J, Crosbie
Publikováno v:
International journal of obesity (2005). 46(3)
The incidence of endometrial cancer is rising in parallel with the obesity epidemic. Obesity increases endometrial cancer risk and weight loss is protective, but the underlying mechanisms are incompletely understood. We hypothesise that the immune mi
Autor:
Y Louise Wan, Roya Behrouzi, Chloe E Barr, Emma J Crosbie, Rhona J McVey, Zoe Maskell, Neil A J Ryan, Katie Stocking, James Bolton, Abigail E. Derbyshire, Philip W. Pemberton
Publikováno v:
Behrouzi, R, Ryan, N, Barr, C, Derbyshire, A, Wan, L, Maskell, Z, Stocking, K, Pemberton, P, Bolton, J, McVey, R J & Crosbie, E 2020, ' Baseline serum HE4 but not tissue HE4 expression predicts response to the levonorgestrel-releasing intrauterine system in atypical hyperplasia and early stage endometrial cancer ', Cancers . https://doi.org/10.3390/cancers12020276
Cancers
Behrouzi, R, Ryan, N A J, Barr, C E, Derbyshire, A E, Wan, Y L, Maskell, Z, Stocking, K, Pemberton, P W, Bolton, J, McVey, R J & Crosbie, E J 2020, ' Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer ', Cancers, vol. 12, no. 2 . https://doi.org/10.3390/cancers12020276
Cancers, Vol 12, Iss 2, p 276 (2020)
Volume 12
Issue 2
Cancers
Behrouzi, R, Ryan, N A J, Barr, C E, Derbyshire, A E, Wan, Y L, Maskell, Z, Stocking, K, Pemberton, P W, Bolton, J, McVey, R J & Crosbie, E J 2020, ' Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer ', Cancers, vol. 12, no. 2 . https://doi.org/10.3390/cancers12020276
Cancers, Vol 12, Iss 2, p 276 (2020)
Volume 12
Issue 2
The levonorgestrel-releasing intrauterine system (LNG-IUS) is a conservative management option for atypical hyperplasia (AH) and low grade early stage endometrial cancer (EEC), but around 1 in 3 patients fail to respond to treatment. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7369e016706a52ad14911956f2ea52b2
https://doi.org/10.3390/cancers12020276
https://doi.org/10.3390/cancers12020276
Autor:
Babur Ahmed, Rhona J McVey, Emma J Crosbie, Martyna Kamieniorz, Catherine L. Higgins, Abigail E. Derbyshire, Basil J. Ammori, Akheel A. Syed, Andrew G Renehan, Philip W. Pemberton, Michelle L. MacKintosh, James Bolton, Henry C Kitchener, Mahshid Nickkho-Amiry, Bilal H. Kirmani
Publikováno v:
Mackintosh, M, Derbyshire, A, McVey, R, Bolton, J, Nickkho-Amiry, M, Higgins, C L, Kamieniorz, M, Pemberton, P W, Kirmani, B H, Ahmed, B, Syed, A, Ammori, B, Renehan, A, Kitchener, H & Crosbie, E 2019, ' The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk ', International Journal of Cancer, vol. 144, no. 3, pp. 641-650 . https://doi.org/10.1002/ijc.31913
International Journal of Cancer
International Journal of Cancer
Obesity is the strongest risk factor for endometrial cancer (EC). To inform targeted screening and prevention strategies, we assessed the impact of obesity and subsequent bariatric surgery‐induced weight loss on endometrial morphology and molecular
Autor:
Abigail E. Derbyshire, Joseph Shaw, Henry C Kitchener, Philip W. Pemberton, Michelle L. MacKintosh, Richard J. Edmondson, Jennifer L. Allen, Emma J Crosbie, Bhavna Lakhiani, James Bolton, Matthew Gittins, Michelle Needham
Publikováno v:
Derbyshire, A E, Allen, J L, Gittins, M, Lakhiani, B, Bolton, J, Shaw, J, Pemberton, P W, Needham, M, MacKintosh, M L, Edmondson, R J, Kitchener, H C & Crosbie, E J 2021, ' PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study ', Cancer Prevention Research, vol. 14, no. 2, pp. 263–274 . https://doi.org/10.1158/1940-6207.CAPR-20-0248
Obesity is the major etiologic driver for endometrial cancer. The levonorgestrel intrauterine system (LNG-IUS) reduces the risk of endometrial cancer and its precursor, atypical hyperplasia. We assessed feasibility and uptake of the LNG-IUS for prima
Autor:
Philip W. Pemberton, Kyle Gilmour, Emma J Crosbie, Henry C Kitchener, Andrew G Renehan, Sarah Kitson, Chris Roberts, Rhona J McVey, Vanitha N Sivalingam, S Ali
Publikováno v:
British Journal of Cancer
Sivalingam, V N, Kitson, S, McVey, R, Roberts, C, Pemberton, P, Gilmour, K, Ali, S, Renehan, A G, Kitchener, H C & Crosbie, E J 2016, ' Measuring the biological effect of presurgical metformin treatment in endometrial cancer ', British Journal of Cancer, vol. 114, no. 3, pp. 281-289 . https://doi.org/10.1038/bjc.2015.453
Sivalingam, V N, Kitson, S, McVey, R, Roberts, C, Pemberton, P, Gilmour, K, Ali, S, Renehan, A G, Kitchener, H C & Crosbie, E J 2016, ' Measuring the biological effect of presurgical metformin treatment in endometrial cancer ', British Journal of Cancer, vol. 114, no. 3, pp. 281-289 . https://doi.org/10.1038/bjc.2015.453
BACKGROUND: Preclinical studies in endometrial cancer (EC) show that metformin reduces cellular proliferation by PI3K-AKT-mTOR inhibition. We tested the hypothesis that short-term presurgical metformin reduces cellular proliferation in atypical endom